series-a
Stage
1
Investors
About
CARGO Therapeutics develops antibody-drug conjugate (ADC) therapies for oncology indications, advancing these treatments from pre-clinical stages toward clinical proof-of-concept.
Explore CARGO Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.